Neumora Therapeutics, Inc. (NMRA) reported Loss for fourth quarter that decreased from the same period last year and beat the Street estimates.
The company's bottom line came in at -$58.82 million, or -$0.37 per share. This compares with -$108.73 million, or -$0.71 per share, last year.
Analysts on average had expected the company to earn -$0.44 per share. Analysts' estimates typically exclude special items.
Neumora Therapeutics, Inc. earnings at a glance (GAAP) :
-Earnings: -$58.82 Mln. vs. -$108.73 Mln. last year.-EPS: -$0.37 vs. -$0.71 last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.